Has Austin Strohbehn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,219 in general payments to Austin Strohbehn, MD across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Austin Strohbehn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Austin Strohbehn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Austin Strohbehn, MD

Retina Specialist · West Des Moines, IANPI 1629482468

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Dutch Ophthalmic, USA at 49.1% of the total. 2025 is the largest year on record at $2,984, 6.9 times the $434 reported in 2019.

$5,219in general payments, 2019–2025

Across 72 payments — averaging $72.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dutch Ophthalmic, USA$3K
Regeneron Healthcare Solutions, Inc.$906
Alcon$584
Apellis Pharmaceuticals, Inc.$224
US Oncology Corporate, Inc.$222
Astellas Pharma US Inc$191
plus $529 from 8 others

$24,148in research payments, 2019–2025

Across 4 payments — averaging $6037.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$22K
AstraZeneca$2K

What the payments were for

Consulting fees$2,25043%
Food & beverage$2,96957%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dutch Ophthalmic, USA	4	$2,563
Regeneron Healthcare Solutions, Inc.	35	$906
Alcon	2	$584
Apellis Pharmaceuticals, Inc.	7	$224
US Oncology Corporate, Inc.	1	$222
Astellas Pharma US Inc	7	$191
Bausch & Lomb Americas Inc.	8	$171
AbbVie	1	$125
Genentech, Inc.	1	$106
Harrow Eye, LLC	2	$62
ANI Pharmaceuticals, Inc.	1	$25
Rxsight Inc	1	$20
Biogen	1	$17
Genentech USA, Inc.	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few retina specialist providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$8,494,508

Medicare patients

1,388

Services billed

159,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	269	$14,268
Bromfenac Sodium	19	$10,026
MoxifloxacinMoxifloxacin Hcl	136	$3,216
Difluprednate	11	$1,288
Dorzolamide Hcl	51	$805
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	49	$681
Ketorolac Tromethamine	17	$625
Brimonidine Tartrate	42	$280
Latanoprost	32	$249
Timolol Maleate	29	$234
ErythromycinErythromycin Base	16	$183

Paid to pharmacies, not to this prescriber.

Other retina specialist in West Des Moines

Sushant WagleyWest Des Moines$6K
James SingerWest Des Moines$3K
Riley BylundWest Des Moines$2K
Christopher HaupertWest Des Moines$1K
David MassopDes Moines$3K
Mohammad SabbaghSioux City$2K
Justin GrassmeyerIowa City$877
Ravi PanditSioux City$855
Beau FennerIowa City$45

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →